TNDM
Tandem Diabetes Care, Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Tandem Diabetes Care (TNDM) Stock: Buy, Sell, or Hold?
$18.71
+0.54 (+2.97%)
▲
5d:
+6.01%
30d:
+13.74%
90d:
-20.18%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect TNDM Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (51%)
Quality Score
49/100
Position
EXTENDED
30-Day Fair Range
$16.10 – $18.64
Position: EXTENDED
Forward P/E & Valuation
147.3x
CHEAP
vs 170.9x historical avg
Wall Street Target
$27.38
+46.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$15.45 / $20.25
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: TNDM shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $18.71, which is considered extended relative to its 30-day fair value range of $16.10 to $18.64. From a valuation perspective, the stock is trading at a discount (Forward PE: 147.3) compared to its historical average (170.9). Remarkably, the market is currently pricing in an annual earnings decline of 4.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. Immediate support is located at $15.45, while resistance sits at $20.25.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.38 (+46.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNDM is in a strong downtrend. Immediate support is located at $15.45, while resistance sits at $20.25.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $27.38 (+46.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.10 -
$18.64
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.0%
Trading Range & Key Levels
30-Day Trading Range
$16.10 -
$18.64
Current vs Trading Range
EXTENDED
Support Level
$15.45
Resistance Level
$20.25
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.3% below Wall St target ($27.38)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
147.32
Wall Street Target
$27.38
(+46.3%)
Revenue Growth (YoY)
13.8%
Earnings Growth (YoY)
-37.0%
Profit Margin
-4.6%
Valuation Discount vs History
-4.8% cheaper
PE vs Historical
147.3 vs 170.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.8%
(market-implied from PE analysis)
1-Year Target
$17.81
(-5%)
2-Year Target
$16.96
(-9%)
3-Year Target
$16.14
(-14%)
3-Yr Target (if PE normalizes)
(PE: 147→171)
$18.73
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 147.3 to 170.9
Stabilization Target:
$21.70
(+16.0%)
PE Expansion Potential:
+16.0%
Share TNDM Analysis
Share this live TNDM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TNDM)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Tandem Diabetes reported upbeat Q3 2026 results with revenue beating estimates, causing the stock to soar. The company expects full-year revenue to be around $1.08 billion.
Key Retail Themes:
Strong Q3 earnings report
Positive revenue guidance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:29 AM ET
Data refreshes hourly during market hours. Next update: 6:29 AM
Data refreshes hourly during market hours. Next update: 6:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TNDM Research Pages
